nodes	percent_of_prediction	percent_of_DWPC	metapath
Salbutamol—CYP3A4—Disulfiram—alcohol dependence	0.152	0.584	CbGbCtD
Salbutamol—CYP3A4—Citalopram—alcohol dependence	0.109	0.416	CbGbCtD
Salbutamol—Phenylephrine—MAOA—alcohol dependence	0.00386	0.753	CrCbGaD
Salbutamol—ADRB2—GPCRs, Other—CHRM2—alcohol dependence	0.00168	0.00834	CbGpPWpGaD
Salbutamol—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.00153	0.0076	CbGpPWpGaD
Salbutamol—ADRB1—Amine ligand-binding receptors—HTR2A—alcohol dependence	0.00151	0.0075	CbGpPWpGaD
Salbutamol—ADRB2—Amine ligand-binding receptors—HTR2A—alcohol dependence	0.00148	0.00734	CbGpPWpGaD
Salbutamol—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00146	0.00723	CbGpPWpGaD
Salbutamol—ADRB1—G alpha (s) signalling events—CRHR1—alcohol dependence	0.00142	0.00708	CbGpPWpGaD
Salbutamol—Haemoglobin—Acamprosate—alcohol dependence	0.00141	0.00265	CcSEcCtD
Salbutamol—Rhinitis—Acamprosate—alcohol dependence	0.00141	0.00264	CcSEcCtD
Salbutamol—Haemorrhage—Acamprosate—alcohol dependence	0.0014	0.00264	CcSEcCtD
Salbutamol—Diabetes mellitus—Citalopram—alcohol dependence	0.0014	0.00263	CcSEcCtD
Salbutamol—Hypoaesthesia—Acamprosate—alcohol dependence	0.0014	0.00262	CcSEcCtD
Salbutamol—Epistaxis—Naltrexone—alcohol dependence	0.0014	0.00262	CcSEcCtD
Salbutamol—Pharyngitis—Acamprosate—alcohol dependence	0.00139	0.00262	CcSEcCtD
Salbutamol—ADRB2—G alpha (s) signalling events—CRHR1—alcohol dependence	0.00139	0.00692	CbGpPWpGaD
Salbutamol—Sinusitis—Naltrexone—alcohol dependence	0.00139	0.00261	CcSEcCtD
Salbutamol—Gastroenteritis—Citalopram—alcohol dependence	0.00137	0.00258	CcSEcCtD
Salbutamol—Eczema—Citalopram—alcohol dependence	0.00135	0.00254	CcSEcCtD
Salbutamol—Dizziness—Disulfiram—alcohol dependence	0.00134	0.00251	CcSEcCtD
Salbutamol—Nasal congestion—Citalopram—alcohol dependence	0.00134	0.00251	CcSEcCtD
Salbutamol—Injury—Citalopram—alcohol dependence	0.00132	0.00249	CcSEcCtD
Salbutamol—ADRB1—GPCRs, Class A Rhodopsin-like—OPRK1—alcohol dependence	0.00132	0.00657	CbGpPWpGaD
Salbutamol—Pharyngitis—Naltrexone—alcohol dependence	0.00132	0.00248	CcSEcCtD
Salbutamol—Tinnitus—Acamprosate—alcohol dependence	0.00131	0.00246	CcSEcCtD
Salbutamol—Connective tissue disorder—Naltrexone—alcohol dependence	0.00131	0.00245	CcSEcCtD
Salbutamol—Increased appetite—Citalopram—alcohol dependence	0.0013	0.00243	CcSEcCtD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—OPRK1—alcohol dependence	0.00129	0.00643	CbGpPWpGaD
Salbutamol—Atrial fibrillation—Citalopram—alcohol dependence	0.00128	0.00241	CcSEcCtD
Salbutamol—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.00128	0.00636	CbGpPWpGaD
Salbutamol—Rash—Disulfiram—alcohol dependence	0.00128	0.0024	CcSEcCtD
Salbutamol—Headache—Disulfiram—alcohol dependence	0.00127	0.00238	CcSEcCtD
Salbutamol—Immune system disorder—Acamprosate—alcohol dependence	0.00127	0.00238	CcSEcCtD
Salbutamol—Norepinephrine—DRD2—alcohol dependence	0.00127	0.247	CrCbGaD
Salbutamol—Chills—Acamprosate—alcohol dependence	0.00126	0.00237	CcSEcCtD
Salbutamol—Hypoglycaemia—Citalopram—alcohol dependence	0.00125	0.00234	CcSEcCtD
Salbutamol—Tinnitus—Naltrexone—alcohol dependence	0.00124	0.00233	CcSEcCtD
Salbutamol—Cardiac disorder—Naltrexone—alcohol dependence	0.00123	0.00232	CcSEcCtD
Salbutamol—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.00123	0.00612	CbGpPWpGaD
Salbutamol—Mental disorder—Acamprosate—alcohol dependence	0.00123	0.00231	CcSEcCtD
Salbutamol—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.00122	0.00608	CbGpPWpGaD
Salbutamol—Malnutrition—Acamprosate—alcohol dependence	0.00122	0.0023	CcSEcCtD
Salbutamol—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00121	0.00599	CbGpPWpGaD
Salbutamol—Angiopathy—Naltrexone—alcohol dependence	0.00121	0.00226	CcSEcCtD
Salbutamol—Flatulence—Acamprosate—alcohol dependence	0.0012	0.00226	CcSEcCtD
Salbutamol—Immune system disorder—Naltrexone—alcohol dependence	0.0012	0.00225	CcSEcCtD
Salbutamol—Tension—Acamprosate—alcohol dependence	0.0012	0.00225	CcSEcCtD
Salbutamol—Affect lability—Citalopram—alcohol dependence	0.0012	0.00225	CcSEcCtD
Salbutamol—Migraine—Citalopram—alcohol dependence	0.0012	0.00225	CcSEcCtD
Salbutamol—Mediastinal disorder—Naltrexone—alcohol dependence	0.0012	0.00225	CcSEcCtD
Salbutamol—Dysgeusia—Acamprosate—alcohol dependence	0.0012	0.00225	CcSEcCtD
Salbutamol—ADRB2—GPCRs, Other—DRD4—alcohol dependence	0.0012	0.00594	CbGpPWpGaD
Salbutamol—Chills—Naltrexone—alcohol dependence	0.00119	0.00224	CcSEcCtD
Salbutamol—Nervousness—Acamprosate—alcohol dependence	0.00119	0.00223	CcSEcCtD
Salbutamol—Back pain—Acamprosate—alcohol dependence	0.00118	0.00222	CcSEcCtD
Salbutamol—Muscle spasms—Acamprosate—alcohol dependence	0.00118	0.00221	CcSEcCtD
Salbutamol—Mental disorder—Naltrexone—alcohol dependence	0.00116	0.00219	CcSEcCtD
Salbutamol—Irritability—Citalopram—alcohol dependence	0.00116	0.00218	CcSEcCtD
Salbutamol—Malnutrition—Naltrexone—alcohol dependence	0.00116	0.00217	CcSEcCtD
Salbutamol—ADRB1—Calcium Regulation in the Cardiac Cell—CHRM2—alcohol dependence	0.00116	0.00575	CbGpPWpGaD
Salbutamol—Mood swings—Citalopram—alcohol dependence	0.00115	0.00216	CcSEcCtD
Salbutamol—Tremor—Acamprosate—alcohol dependence	0.00115	0.00215	CcSEcCtD
Salbutamol—Ataxia—Citalopram—alcohol dependence	0.00114	0.00215	CcSEcCtD
Salbutamol—ADRB2—GPCRs, Other—CNR1—alcohol dependence	0.00114	0.00567	CbGpPWpGaD
Salbutamol—Flatulence—Naltrexone—alcohol dependence	0.00114	0.00214	CcSEcCtD
Salbutamol—Tension—Naltrexone—alcohol dependence	0.00113	0.00213	CcSEcCtD
Salbutamol—Ill-defined disorder—Acamprosate—alcohol dependence	0.00113	0.00213	CcSEcCtD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—OPRK1—alcohol dependence	0.00113	0.00563	CbGpPWpGaD
Salbutamol—Dysgeusia—Naltrexone—alcohol dependence	0.00113	0.00213	CcSEcCtD
Salbutamol—ADRB2—Calcium Regulation in the Cardiac Cell—CHRM2—alcohol dependence	0.00113	0.00562	CbGpPWpGaD
Salbutamol—Agitation—Acamprosate—alcohol dependence	0.00112	0.00211	CcSEcCtD
Salbutamol—Nervousness—Naltrexone—alcohol dependence	0.00112	0.00211	CcSEcCtD
Salbutamol—Back pain—Naltrexone—alcohol dependence	0.00112	0.0021	CcSEcCtD
Salbutamol—Angioedema—Acamprosate—alcohol dependence	0.00112	0.0021	CcSEcCtD
Salbutamol—ADRB2—GPCRs, Other—HTR7—alcohol dependence	0.00111	0.00553	CbGpPWpGaD
Salbutamol—Muscle spasms—Naltrexone—alcohol dependence	0.00111	0.00209	CcSEcCtD
Salbutamol—Abdominal pain upper—Citalopram—alcohol dependence	0.00111	0.00209	CcSEcCtD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—OPRK1—alcohol dependence	0.00111	0.00551	CbGpPWpGaD
Salbutamol—Hypokalaemia—Citalopram—alcohol dependence	0.00111	0.00208	CcSEcCtD
Salbutamol—Malaise—Acamprosate—alcohol dependence	0.0011	0.00207	CcSEcCtD
Salbutamol—Vertigo—Acamprosate—alcohol dependence	0.0011	0.00206	CcSEcCtD
Salbutamol—Syncope—Acamprosate—alcohol dependence	0.0011	0.00206	CcSEcCtD
Salbutamol—Cramp muscle—Citalopram—alcohol dependence	0.0011	0.00206	CcSEcCtD
Salbutamol—ADRB1—G alpha (s) signalling events—CRH—alcohol dependence	0.00109	0.00542	CbGpPWpGaD
Salbutamol—Nasopharyngitis—Citalopram—alcohol dependence	0.00109	0.00204	CcSEcCtD
Salbutamol—Tremor—Naltrexone—alcohol dependence	0.00108	0.00203	CcSEcCtD
Salbutamol—Palpitations—Acamprosate—alcohol dependence	0.00108	0.00203	CcSEcCtD
Salbutamol—Loss of consciousness—Acamprosate—alcohol dependence	0.00107	0.00202	CcSEcCtD
Salbutamol—Ill-defined disorder—Naltrexone—alcohol dependence	0.00107	0.00201	CcSEcCtD
Salbutamol—ADRB2—G alpha (s) signalling events—CRH—alcohol dependence	0.00107	0.00531	CbGpPWpGaD
Salbutamol—Cough—Acamprosate—alcohol dependence	0.00107	0.002	CcSEcCtD
Salbutamol—Agitation—Naltrexone—alcohol dependence	0.00106	0.002	CcSEcCtD
Salbutamol—Abdominal distension—Citalopram—alcohol dependence	0.00106	0.00199	CcSEcCtD
Salbutamol—Angioedema—Naltrexone—alcohol dependence	0.00106	0.00198	CcSEcCtD
Salbutamol—Hypertension—Acamprosate—alcohol dependence	0.00106	0.00198	CcSEcCtD
Salbutamol—Asthma—Citalopram—alcohol dependence	0.00105	0.00197	CcSEcCtD
Salbutamol—Influenza—Citalopram—alcohol dependence	0.00105	0.00197	CcSEcCtD
Salbutamol—Malaise—Naltrexone—alcohol dependence	0.00104	0.00196	CcSEcCtD
Salbutamol—Arthralgia—Acamprosate—alcohol dependence	0.00104	0.00195	CcSEcCtD
Salbutamol—Chest pain—Acamprosate—alcohol dependence	0.00104	0.00195	CcSEcCtD
Salbutamol—Myalgia—Acamprosate—alcohol dependence	0.00104	0.00195	CcSEcCtD
Salbutamol—Syncope—Naltrexone—alcohol dependence	0.00104	0.00195	CcSEcCtD
Salbutamol—Anxiety—Acamprosate—alcohol dependence	0.00104	0.00195	CcSEcCtD
Salbutamol—Bronchospasm—Citalopram—alcohol dependence	0.00103	0.00194	CcSEcCtD
Salbutamol—Discomfort—Acamprosate—alcohol dependence	0.00103	0.00193	CcSEcCtD
Salbutamol—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.00103	0.0051	CbGpPWpGaD
Salbutamol—Sweating increased—Citalopram—alcohol dependence	0.00102	0.00192	CcSEcCtD
Salbutamol—Angina pectoris—Citalopram—alcohol dependence	0.00102	0.00192	CcSEcCtD
Salbutamol—Palpitations—Naltrexone—alcohol dependence	0.00102	0.00192	CcSEcCtD
Salbutamol—Dry mouth—Acamprosate—alcohol dependence	0.00102	0.00191	CcSEcCtD
Salbutamol—Loss of consciousness—Naltrexone—alcohol dependence	0.00102	0.00191	CcSEcCtD
Salbutamol—Bronchitis—Citalopram—alcohol dependence	0.00101	0.0019	CcSEcCtD
Salbutamol—Cough—Naltrexone—alcohol dependence	0.00101	0.00189	CcSEcCtD
Salbutamol—Hypertension—Naltrexone—alcohol dependence	0.000998	0.00187	CcSEcCtD
Salbutamol—Anaphylactic shock—Acamprosate—alcohol dependence	0.000998	0.00187	CcSEcCtD
Salbutamol—Infection—Acamprosate—alcohol dependence	0.000991	0.00186	CcSEcCtD
Salbutamol—Myalgia—Naltrexone—alcohol dependence	0.000985	0.00185	CcSEcCtD
Salbutamol—Chest pain—Naltrexone—alcohol dependence	0.000985	0.00185	CcSEcCtD
Salbutamol—Arthralgia—Naltrexone—alcohol dependence	0.000985	0.00185	CcSEcCtD
Salbutamol—Dysuria—Citalopram—alcohol dependence	0.000983	0.00185	CcSEcCtD
Salbutamol—Shock—Acamprosate—alcohol dependence	0.000981	0.00184	CcSEcCtD
Salbutamol—Anxiety—Naltrexone—alcohol dependence	0.000981	0.00184	CcSEcCtD
Salbutamol—Upper respiratory tract infection—Citalopram—alcohol dependence	0.000977	0.00184	CcSEcCtD
Salbutamol—Tachycardia—Acamprosate—alcohol dependence	0.000974	0.00183	CcSEcCtD
Salbutamol—Discomfort—Naltrexone—alcohol dependence	0.000973	0.00183	CcSEcCtD
Salbutamol—Skin disorder—Acamprosate—alcohol dependence	0.000969	0.00182	CcSEcCtD
Salbutamol—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000967	0.0048	CbGpPWpGaD
Salbutamol—Hyperhidrosis—Acamprosate—alcohol dependence	0.000964	0.00181	CcSEcCtD
Salbutamol—Dry mouth—Naltrexone—alcohol dependence	0.000963	0.00181	CcSEcCtD
Salbutamol—Anorexia—Acamprosate—alcohol dependence	0.000951	0.00179	CcSEcCtD
Salbutamol—Hyperglycaemia—Citalopram—alcohol dependence	0.000949	0.00178	CcSEcCtD
Salbutamol—Oedema—Naltrexone—alcohol dependence	0.000944	0.00177	CcSEcCtD
Salbutamol—Anaphylactic shock—Naltrexone—alcohol dependence	0.000944	0.00177	CcSEcCtD
Salbutamol—Infection—Naltrexone—alcohol dependence	0.000938	0.00176	CcSEcCtD
Salbutamol—Hypotension—Acamprosate—alcohol dependence	0.000932	0.00175	CcSEcCtD
Salbutamol—Shock—Naltrexone—alcohol dependence	0.000929	0.00174	CcSEcCtD
Salbutamol—Nervous system disorder—Naltrexone—alcohol dependence	0.000926	0.00174	CcSEcCtD
Salbutamol—Tachycardia—Naltrexone—alcohol dependence	0.000921	0.00173	CcSEcCtD
Salbutamol—Neuropathy peripheral—Citalopram—alcohol dependence	0.000919	0.00173	CcSEcCtD
Salbutamol—Skin disorder—Naltrexone—alcohol dependence	0.000917	0.00172	CcSEcCtD
Salbutamol—Stomatitis—Citalopram—alcohol dependence	0.000914	0.00172	CcSEcCtD
Salbutamol—Jaundice—Citalopram—alcohol dependence	0.000914	0.00172	CcSEcCtD
Salbutamol—Hyperhidrosis—Naltrexone—alcohol dependence	0.000912	0.00171	CcSEcCtD
Salbutamol—Conjunctivitis—Citalopram—alcohol dependence	0.000911	0.00171	CcSEcCtD
Salbutamol—Urinary tract infection—Citalopram—alcohol dependence	0.000911	0.00171	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000909	0.00171	CcSEcCtD
Salbutamol—Insomnia—Acamprosate—alcohol dependence	0.000902	0.00169	CcSEcCtD
Salbutamol—Anorexia—Naltrexone—alcohol dependence	0.0009	0.00169	CcSEcCtD
Salbutamol—Sweating—Citalopram—alcohol dependence	0.000899	0.00169	CcSEcCtD
Salbutamol—Paraesthesia—Acamprosate—alcohol dependence	0.000896	0.00168	CcSEcCtD
Salbutamol—Haematuria—Citalopram—alcohol dependence	0.000894	0.00168	CcSEcCtD
Salbutamol—Dyspnoea—Acamprosate—alcohol dependence	0.000889	0.00167	CcSEcCtD
Salbutamol—ADRB1—GPCRs, Class A Rhodopsin-like—OPRD1—alcohol dependence	0.000889	0.00442	CbGpPWpGaD
Salbutamol—ADRB1—G alpha (s) signalling events—HTR7—alcohol dependence	0.000889	0.00442	CbGpPWpGaD
Salbutamol—Somnolence—Acamprosate—alcohol dependence	0.000887	0.00167	CcSEcCtD
Salbutamol—Epistaxis—Citalopram—alcohol dependence	0.000884	0.00166	CcSEcCtD
Salbutamol—Sinusitis—Citalopram—alcohol dependence	0.00088	0.00165	CcSEcCtD
Salbutamol—Dyspepsia—Acamprosate—alcohol dependence	0.000878	0.00165	CcSEcCtD
Salbutamol—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000872	0.00433	CbGpPWpGaD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—OPRD1—alcohol dependence	0.00087	0.00432	CbGpPWpGaD
Salbutamol—ADRB2—G alpha (s) signalling events—HTR7—alcohol dependence	0.000869	0.00432	CbGpPWpGaD
Salbutamol—Decreased appetite—Acamprosate—alcohol dependence	0.000867	0.00163	CcSEcCtD
Salbutamol—ADRB1—GPCR ligand binding—OPRK1—alcohol dependence	0.000863	0.00429	CbGpPWpGaD
Salbutamol—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000861	0.00162	CcSEcCtD
Salbutamol—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.00086	0.00161	CcSEcCtD
Salbutamol—Insomnia—Naltrexone—alcohol dependence	0.000854	0.0016	CcSEcCtD
Salbutamol—Pain—Acamprosate—alcohol dependence	0.000853	0.0016	CcSEcCtD
Salbutamol—Constipation—Acamprosate—alcohol dependence	0.000853	0.0016	CcSEcCtD
Salbutamol—Paraesthesia—Naltrexone—alcohol dependence	0.000848	0.00159	CcSEcCtD
Salbutamol—Haemoglobin—Citalopram—alcohol dependence	0.000846	0.00159	CcSEcCtD
Salbutamol—ADRB2—GPCR ligand binding—OPRK1—alcohol dependence	0.000844	0.0042	CbGpPWpGaD
Salbutamol—Rhinitis—Citalopram—alcohol dependence	0.000844	0.00158	CcSEcCtD
Salbutamol—Haemorrhage—Citalopram—alcohol dependence	0.000842	0.00158	CcSEcCtD
Salbutamol—Dyspnoea—Naltrexone—alcohol dependence	0.000841	0.00158	CcSEcCtD
Salbutamol—Somnolence—Naltrexone—alcohol dependence	0.000839	0.00158	CcSEcCtD
Salbutamol—Hypoaesthesia—Citalopram—alcohol dependence	0.000838	0.00157	CcSEcCtD
Salbutamol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000837	0.00416	CbGpPWpGaD
Salbutamol—Pharyngitis—Citalopram—alcohol dependence	0.000835	0.00157	CcSEcCtD
Salbutamol—Urinary tract disorder—Citalopram—alcohol dependence	0.000831	0.00156	CcSEcCtD
Salbutamol—Connective tissue disorder—Citalopram—alcohol dependence	0.000827	0.00155	CcSEcCtD
Salbutamol—Urethral disorder—Citalopram—alcohol dependence	0.000825	0.00155	CcSEcCtD
Salbutamol—Feeling abnormal—Acamprosate—alcohol dependence	0.000822	0.00154	CcSEcCtD
Salbutamol—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000822	0.00409	CbGpPWpGaD
Salbutamol—Decreased appetite—Naltrexone—alcohol dependence	0.00082	0.00154	CcSEcCtD
Salbutamol—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000816	0.00153	CcSEcCtD
Salbutamol—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000815	0.00153	CcSEcCtD
Salbutamol—Fatigue—Naltrexone—alcohol dependence	0.000814	0.00153	CcSEcCtD
Salbutamol—Pain—Naltrexone—alcohol dependence	0.000807	0.00152	CcSEcCtD
Salbutamol—Constipation—Naltrexone—alcohol dependence	0.000807	0.00152	CcSEcCtD
Salbutamol—Urticaria—Acamprosate—alcohol dependence	0.000792	0.00149	CcSEcCtD
Salbutamol—Body temperature increased—Acamprosate—alcohol dependence	0.000789	0.00148	CcSEcCtD
Salbutamol—Abdominal pain—Acamprosate—alcohol dependence	0.000789	0.00148	CcSEcCtD
Salbutamol—Tinnitus—Citalopram—alcohol dependence	0.000785	0.00147	CcSEcCtD
Salbutamol—Flushing—Citalopram—alcohol dependence	0.000781	0.00147	CcSEcCtD
Salbutamol—Cardiac disorder—Citalopram—alcohol dependence	0.000781	0.00147	CcSEcCtD
Salbutamol—ADRB2—GPCRs, Other—HTR2A—alcohol dependence	0.00078	0.00388	CbGpPWpGaD
Salbutamol—Feeling abnormal—Naltrexone—alcohol dependence	0.000778	0.00146	CcSEcCtD
Salbutamol—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000773	0.00384	CbGpPWpGaD
Salbutamol—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000772	0.00145	CcSEcCtD
Salbutamol—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000765	0.0038	CbGpPWpGaD
Salbutamol—Angiopathy—Citalopram—alcohol dependence	0.000764	0.00143	CcSEcCtD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—OPRD1—alcohol dependence	0.000762	0.00379	CbGpPWpGaD
Salbutamol—Immune system disorder—Citalopram—alcohol dependence	0.00076	0.00143	CcSEcCtD
Salbutamol—Mediastinal disorder—Citalopram—alcohol dependence	0.000759	0.00142	CcSEcCtD
Salbutamol—Chills—Citalopram—alcohol dependence	0.000755	0.00142	CcSEcCtD
Salbutamol—Arrhythmia—Citalopram—alcohol dependence	0.000752	0.00141	CcSEcCtD
Salbutamol—Urticaria—Naltrexone—alcohol dependence	0.00075	0.00141	CcSEcCtD
Salbutamol—ADRB1—G alpha (s) signalling events—AVP—alcohol dependence	0.000748	0.00372	CbGpPWpGaD
Salbutamol—Abdominal pain—Naltrexone—alcohol dependence	0.000746	0.0014	CcSEcCtD
Salbutamol—Body temperature increased—Naltrexone—alcohol dependence	0.000746	0.0014	CcSEcCtD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—OPRD1—alcohol dependence	0.000745	0.0037	CbGpPWpGaD
Salbutamol—ADRB1—GPCRs, Class A Rhodopsin-like—CHRM2—alcohol dependence	0.000745	0.0037	CbGpPWpGaD
Salbutamol—Mental disorder—Citalopram—alcohol dependence	0.000737	0.00138	CcSEcCtD
Salbutamol—Hypersensitivity—Acamprosate—alcohol dependence	0.000735	0.00138	CcSEcCtD
Salbutamol—Malnutrition—Citalopram—alcohol dependence	0.000733	0.00138	CcSEcCtD
Salbutamol—ADRB2—G alpha (s) signalling events—AVP—alcohol dependence	0.000732	0.00364	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PDYN—alcohol dependence	0.00073	0.00363	CbGpPWpGaD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—CHRM2—alcohol dependence	0.000729	0.00362	CbGpPWpGaD
Salbutamol—Flatulence—Citalopram—alcohol dependence	0.000722	0.00136	CcSEcCtD
Salbutamol—Tension—Citalopram—alcohol dependence	0.000719	0.00135	CcSEcCtD
Salbutamol—Dysgeusia—Citalopram—alcohol dependence	0.000718	0.00135	CcSEcCtD
Salbutamol—Asthenia—Acamprosate—alcohol dependence	0.000716	0.00134	CcSEcCtD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PDYN—alcohol dependence	0.000714	0.00355	CbGpPWpGaD
Salbutamol—Nervousness—Citalopram—alcohol dependence	0.000712	0.00134	CcSEcCtD
Salbutamol—Back pain—Citalopram—alcohol dependence	0.000709	0.00133	CcSEcCtD
Salbutamol—Pruritus—Acamprosate—alcohol dependence	0.000706	0.00133	CcSEcCtD
Salbutamol—Muscle spasms—Citalopram—alcohol dependence	0.000704	0.00132	CcSEcCtD
Salbutamol—Hypersensitivity—Naltrexone—alcohol dependence	0.000695	0.00131	CcSEcCtD
Salbutamol—Tremor—Citalopram—alcohol dependence	0.000687	0.00129	CcSEcCtD
Salbutamol—ADRB1—GPCRs, Class A Rhodopsin-like—OPRM1—alcohol dependence	0.000684	0.0034	CbGpPWpGaD
Salbutamol—Diarrhoea—Acamprosate—alcohol dependence	0.000683	0.00128	CcSEcCtD
Salbutamol—Ill-defined disorder—Citalopram—alcohol dependence	0.00068	0.00128	CcSEcCtD
Salbutamol—Asthenia—Naltrexone—alcohol dependence	0.000677	0.00127	CcSEcCtD
Salbutamol—Agitation—Citalopram—alcohol dependence	0.000673	0.00126	CcSEcCtD
Salbutamol—Angioedema—Citalopram—alcohol dependence	0.00067	0.00126	CcSEcCtD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—OPRM1—alcohol dependence	0.000669	0.00333	CbGpPWpGaD
Salbutamol—Pruritus—Naltrexone—alcohol dependence	0.000668	0.00125	CcSEcCtD
Salbutamol—Malaise—Citalopram—alcohol dependence	0.000661	0.00124	CcSEcCtD
Salbutamol—Dizziness—Acamprosate—alcohol dependence	0.00066	0.00124	CcSEcCtD
Salbutamol—Vertigo—Citalopram—alcohol dependence	0.000658	0.00124	CcSEcCtD
Salbutamol—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000657	0.00327	CbGpPWpGaD
Salbutamol—Syncope—Citalopram—alcohol dependence	0.000657	0.00123	CcSEcCtD
Salbutamol—Palpitations—Citalopram—alcohol dependence	0.000648	0.00122	CcSEcCtD
Salbutamol—Diarrhoea—Naltrexone—alcohol dependence	0.000646	0.00121	CcSEcCtD
Salbutamol—Loss of consciousness—Citalopram—alcohol dependence	0.000644	0.00121	CcSEcCtD
Salbutamol—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000641	0.00318	CbGpPWpGaD
Salbutamol—Cough—Citalopram—alcohol dependence	0.000639	0.0012	CcSEcCtD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CHRM2—alcohol dependence	0.000638	0.00317	CbGpPWpGaD
Salbutamol—Vomiting—Acamprosate—alcohol dependence	0.000634	0.00119	CcSEcCtD
Salbutamol—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000634	0.00315	CbGpPWpGaD
Salbutamol—Hypertension—Citalopram—alcohol dependence	0.000633	0.00119	CcSEcCtD
Salbutamol—Rash—Acamprosate—alcohol dependence	0.000629	0.00118	CcSEcCtD
Salbutamol—Dermatitis—Acamprosate—alcohol dependence	0.000628	0.00118	CcSEcCtD
Salbutamol—Headache—Acamprosate—alcohol dependence	0.000625	0.00117	CcSEcCtD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CHRM2—alcohol dependence	0.000624	0.0031	CbGpPWpGaD
Salbutamol—Dizziness—Naltrexone—alcohol dependence	0.000624	0.00117	CcSEcCtD
Salbutamol—Myalgia—Citalopram—alcohol dependence	0.000624	0.00117	CcSEcCtD
Salbutamol—Chest pain—Citalopram—alcohol dependence	0.000624	0.00117	CcSEcCtD
Salbutamol—Arthralgia—Citalopram—alcohol dependence	0.000624	0.00117	CcSEcCtD
Salbutamol—Anxiety—Citalopram—alcohol dependence	0.000622	0.00117	CcSEcCtD
Salbutamol—Discomfort—Citalopram—alcohol dependence	0.000616	0.00116	CcSEcCtD
Salbutamol—Dry mouth—Citalopram—alcohol dependence	0.00061	0.00115	CcSEcCtD
Salbutamol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR1B—alcohol dependence	0.000607	0.00302	CbGpPWpGaD
Salbutamol—Vomiting—Naltrexone—alcohol dependence	0.0006	0.00113	CcSEcCtD
Salbutamol—Anaphylactic shock—Citalopram—alcohol dependence	0.000598	0.00112	CcSEcCtD
Salbutamol—Oedema—Citalopram—alcohol dependence	0.000598	0.00112	CcSEcCtD
Salbutamol—Rash—Naltrexone—alcohol dependence	0.000595	0.00112	CcSEcCtD
Salbutamol—Dermatitis—Naltrexone—alcohol dependence	0.000595	0.00112	CcSEcCtD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR1B—alcohol dependence	0.000594	0.00295	CbGpPWpGaD
Salbutamol—Infection—Citalopram—alcohol dependence	0.000594	0.00112	CcSEcCtD
Salbutamol—Nausea—Acamprosate—alcohol dependence	0.000593	0.00111	CcSEcCtD
Salbutamol—Headache—Naltrexone—alcohol dependence	0.000591	0.00111	CcSEcCtD
Salbutamol—Shock—Citalopram—alcohol dependence	0.000588	0.0011	CcSEcCtD
Salbutamol—Nervous system disorder—Citalopram—alcohol dependence	0.000586	0.0011	CcSEcCtD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—OPRM1—alcohol dependence	0.000586	0.00291	CbGpPWpGaD
Salbutamol—Tachycardia—Citalopram—alcohol dependence	0.000584	0.0011	CcSEcCtD
Salbutamol—Skin disorder—Citalopram—alcohol dependence	0.000581	0.00109	CcSEcCtD
Salbutamol—ADRB1—GPCR ligand binding—OPRD1—alcohol dependence	0.00058	0.00288	CbGpPWpGaD
Salbutamol—Hyperhidrosis—Citalopram—alcohol dependence	0.000578	0.00109	CcSEcCtD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—OPRM1—alcohol dependence	0.000573	0.00285	CbGpPWpGaD
Salbutamol—Anorexia—Citalopram—alcohol dependence	0.00057	0.00107	CcSEcCtD
Salbutamol—ADRB2—GPCR ligand binding—OPRD1—alcohol dependence	0.000567	0.00282	CbGpPWpGaD
Salbutamol—Nausea—Naltrexone—alcohol dependence	0.000561	0.00105	CcSEcCtD
Salbutamol—Hypotension—Citalopram—alcohol dependence	0.000559	0.00105	CcSEcCtD
Salbutamol—ADRB1—GPCR ligand binding—PDYN—alcohol dependence	0.000556	0.00276	CbGpPWpGaD
Salbutamol—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000545	0.00102	CcSEcCtD
Salbutamol—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000545	0.00271	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—PDYN—alcohol dependence	0.000544	0.0027	CbGpPWpGaD
Salbutamol—Insomnia—Citalopram—alcohol dependence	0.000541	0.00102	CcSEcCtD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPY—alcohol dependence	0.000539	0.00268	CbGpPWpGaD
Salbutamol—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000539	0.00268	CbGpPWpGaD
Salbutamol—Paraesthesia—Citalopram—alcohol dependence	0.000537	0.00101	CcSEcCtD
Salbutamol—Dyspnoea—Citalopram—alcohol dependence	0.000533	0.001	CcSEcCtD
Salbutamol—Somnolence—Citalopram—alcohol dependence	0.000532	0.000998	CcSEcCtD
Salbutamol—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000531	0.00264	CbGpPWpGaD
Salbutamol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—alcohol dependence	0.000531	0.00264	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPY—alcohol dependence	0.000528	0.00262	CbGpPWpGaD
Salbutamol—Dyspepsia—Citalopram—alcohol dependence	0.000526	0.000988	CcSEcCtD
Salbutamol—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000524	0.00261	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR1B—alcohol dependence	0.00052	0.00259	CbGpPWpGaD
Salbutamol—Decreased appetite—Citalopram—alcohol dependence	0.00052	0.000976	CcSEcCtD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—alcohol dependence	0.000519	0.00258	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—CRHR1—alcohol dependence	0.000517	0.00257	CbGpPWpGaD
Salbutamol—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000516	0.000969	CcSEcCtD
Salbutamol—Fatigue—Citalopram—alcohol dependence	0.000516	0.000968	CcSEcCtD
Salbutamol—Pain—Citalopram—alcohol dependence	0.000511	0.00096	CcSEcCtD
Salbutamol—Constipation—Citalopram—alcohol dependence	0.000511	0.00096	CcSEcCtD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR1B—alcohol dependence	0.000509	0.00253	CbGpPWpGaD
Salbutamol—ADRB1—GPCRs, Class A Rhodopsin-like—CNR1—alcohol dependence	0.000507	0.00252	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—CRHR1—alcohol dependence	0.000506	0.00251	CbGpPWpGaD
Salbutamol—ADRB1—G alpha (s) signalling events—POMC—alcohol dependence	0.000497	0.00247	CbGpPWpGaD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—CNR1—alcohol dependence	0.000496	0.00246	CbGpPWpGaD
Salbutamol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR7—alcohol dependence	0.000495	0.00246	CbGpPWpGaD
Salbutamol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—alcohol dependence	0.000495	0.00246	CbGpPWpGaD
Salbutamol—Feeling abnormal—Citalopram—alcohol dependence	0.000493	0.000925	CcSEcCtD
Salbutamol—Gastrointestinal pain—Citalopram—alcohol dependence	0.000489	0.000918	CcSEcCtD
Salbutamol—ADRB1—GPCR downstream signaling—OPRK1—alcohol dependence	0.000488	0.00242	CbGpPWpGaD
Salbutamol—ADRB2—G alpha (s) signalling events—POMC—alcohol dependence	0.000486	0.00242	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—CHRM2—alcohol dependence	0.000486	0.00242	CbGpPWpGaD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—alcohol dependence	0.000484	0.0024	CbGpPWpGaD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR7—alcohol dependence	0.000484	0.0024	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—OPRK1—alcohol dependence	0.000477	0.00237	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—CHRM2—alcohol dependence	0.000476	0.00236	CbGpPWpGaD
Salbutamol—Urticaria—Citalopram—alcohol dependence	0.000475	0.000892	CcSEcCtD
Salbutamol—Body temperature increased—Citalopram—alcohol dependence	0.000473	0.000888	CcSEcCtD
Salbutamol—Abdominal pain—Citalopram—alcohol dependence	0.000473	0.000888	CcSEcCtD
Salbutamol—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.000463	0.0023	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—alcohol dependence	0.000455	0.00226	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—OPRM1—alcohol dependence	0.000446	0.00222	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—alcohol dependence	0.000445	0.00221	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.000444	0.00221	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—OPRK1—alcohol dependence	0.000443	0.0022	CbGpPWpGaD
Salbutamol—Hypersensitivity—Citalopram—alcohol dependence	0.000441	0.000827	CcSEcCtD
Salbutamol—ADRB2—GPCR ligand binding—OPRM1—alcohol dependence	0.000437	0.00217	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CNR1—alcohol dependence	0.000434	0.00216	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—OPRK1—alcohol dependence	0.000433	0.00215	CbGpPWpGaD
Salbutamol—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000431	0.00214	CbGpPWpGaD
Salbutamol—Asthenia—Citalopram—alcohol dependence	0.000429	0.000806	CcSEcCtD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CNR1—alcohol dependence	0.000425	0.00211	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	0.000424	0.00211	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	0.000424	0.00211	CbGpPWpGaD
Salbutamol—Pruritus—Citalopram—alcohol dependence	0.000423	0.000794	CcSEcCtD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	0.000414	0.00206	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	0.000414	0.00206	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—NPY—alcohol dependence	0.000411	0.00204	CbGpPWpGaD
Salbutamol—Diarrhoea—Citalopram—alcohol dependence	0.000409	0.000768	CcSEcCtD
Salbutamol—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000406	0.00202	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—NPY—alcohol dependence	0.000402	0.002	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—CRH—alcohol dependence	0.000396	0.00197	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—HTR1B—alcohol dependence	0.000396	0.00197	CbGpPWpGaD
Salbutamol—Dizziness—Citalopram—alcohol dependence	0.000395	0.000743	CcSEcCtD
Salbutamol—ADRB2—GPCR ligand binding—HTR1B—alcohol dependence	0.000388	0.00193	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—CRH—alcohol dependence	0.000388	0.00193	CbGpPWpGaD
Salbutamol—Vomiting—Citalopram—alcohol dependence	0.00038	0.000714	CcSEcCtD
Salbutamol—Rash—Citalopram—alcohol dependence	0.000377	0.000708	CcSEcCtD
Salbutamol—Dermatitis—Citalopram—alcohol dependence	0.000377	0.000707	CcSEcCtD
Salbutamol—Headache—Citalopram—alcohol dependence	0.000375	0.000703	CcSEcCtD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	0.000357	0.00177	CbGpPWpGaD
Salbutamol—Nausea—Citalopram—alcohol dependence	0.000355	0.000667	CcSEcCtD
Salbutamol—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000354	0.00176	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	0.000349	0.00173	CbGpPWpGaD
Salbutamol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	0.000346	0.00172	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—DRD4—alcohol dependence	0.000346	0.00172	CbGpPWpGaD
Salbutamol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—alcohol dependence	0.000339	0.00168	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—DRD4—alcohol dependence	0.000339	0.00168	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000337	0.00167	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—CNR1—alcohol dependence	0.000331	0.00164	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—OPRD1—alcohol dependence	0.000328	0.00163	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—CNR1—alcohol dependence	0.000324	0.00161	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—DRD2—alcohol dependence	0.000323	0.0016	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—HTR7—alcohol dependence	0.000323	0.0016	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—OPRD1—alcohol dependence	0.000321	0.00159	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—HTR7—alcohol dependence	0.000316	0.00157	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—DRD2—alcohol dependence	0.000316	0.00157	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—PDYN—alcohol dependence	0.000314	0.00156	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—PDYN—alcohol dependence	0.000307	0.00153	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—OPRD1—alcohol dependence	0.000298	0.00148	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	0.000297	0.00147	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—CRHR1—alcohol dependence	0.000292	0.00145	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—OPRD1—alcohol dependence	0.000291	0.00145	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	0.00029	0.00144	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.000286	0.00142	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—CRHR1—alcohol dependence	0.000286	0.00142	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—PDYN—alcohol dependence	0.000285	0.00142	CbGpPWpGaD
Salbutamol—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000285	0.00141	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—PDYN—alcohol dependence	0.000279	0.00139	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—CHRM2—alcohol dependence	0.000275	0.00137	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—AVP—alcohol dependence	0.000272	0.00135	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—CHRM2—alcohol dependence	0.000269	0.00134	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—AVP—alcohol dependence	0.000266	0.00132	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CRHR1—alcohol dependence	0.000265	0.00132	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—OPRK1—alcohol dependence	0.000262	0.0013	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CRHR1—alcohol dependence	0.00026	0.00129	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—OPRK1—alcohol dependence	0.000256	0.00127	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—OPRM1—alcohol dependence	0.000252	0.00125	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CHRM2—alcohol dependence	0.000249	0.00124	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—OPRM1—alcohol dependence	0.000247	0.00123	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CHRM2—alcohol dependence	0.000244	0.00121	CbGpPWpGaD
Salbutamol—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	0.000237	0.00118	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—NPY—alcohol dependence	0.000232	0.00115	CbGpPWpGaD
Salbutamol—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	0.000232	0.00115	CbGpPWpGaD
Salbutamol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000231	0.00115	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—OPRM1—alcohol dependence	0.000229	0.00114	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	0.000229	0.00114	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—NPY—alcohol dependence	0.000227	0.00113	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—HTR2A—alcohol dependence	0.000226	0.00112	CbGpPWpGaD
Salbutamol—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000226	0.00112	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—OPRM1—alcohol dependence	0.000224	0.00111	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—CRH—alcohol dependence	0.000224	0.00111	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—HTR1B—alcohol dependence	0.000224	0.00111	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—HTR2A—alcohol dependence	0.000221	0.0011	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—HTR1B—alcohol dependence	0.000219	0.00109	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—CRH—alcohol dependence	0.000219	0.00109	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—NPY—alcohol dependence	0.000211	0.00105	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—GGT1—alcohol dependence	0.00021	0.00104	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—NPY—alcohol dependence	0.000206	0.00102	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CRH—alcohol dependence	0.000203	0.00101	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—HTR1B—alcohol dependence	0.000203	0.00101	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—HTR1B—alcohol dependence	0.000199	0.000989	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CRH—alcohol dependence	0.000199	0.000989	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—DRD4—alcohol dependence	0.000196	0.000973	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—DRD4—alcohol dependence	0.000191	0.000952	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—MAOA—alcohol dependence	0.000188	0.000936	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—CNR1—alcohol dependence	0.000187	0.000929	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—CNR1—alcohol dependence	0.000183	0.000909	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—HTR7—alcohol dependence	0.000182	0.000906	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—DRD2—alcohol dependence	0.000182	0.000906	CbGpPWpGaD
Salbutamol—ADRB1—GPCR ligand binding—POMC—alcohol dependence	0.00018	0.000897	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—HTR7—alcohol dependence	0.000178	0.000887	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—DRD2—alcohol dependence	0.000178	0.000887	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—DRD4—alcohol dependence	0.000178	0.000883	CbGpPWpGaD
Salbutamol—ADRB2—GPCR ligand binding—POMC—alcohol dependence	0.000177	0.000877	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—OPRD1—alcohol dependence	0.000176	0.000874	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—DRD4—alcohol dependence	0.000174	0.000864	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—OPRD1—alcohol dependence	0.000172	0.000855	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—CNR1—alcohol dependence	0.00017	0.000844	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—PDYN—alcohol dependence	0.000169	0.000838	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—CNR1—alcohol dependence	0.000166	0.000825	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—DRD2—alcohol dependence	0.000166	0.000823	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—HTR7—alcohol dependence	0.000166	0.000823	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—PDYN—alcohol dependence	0.000165	0.00082	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—HTR7—alcohol dependence	0.000162	0.000805	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—DRD2—alcohol dependence	0.000162	0.000805	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CRHR1—alcohol dependence	0.000157	0.000779	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—WASF2—alcohol dependence	0.000157	0.000779	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—AVP—alcohol dependence	0.000153	0.000763	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CRHR1—alcohol dependence	0.000153	0.000762	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—WASF2—alcohol dependence	0.000153	0.000762	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—WASF1—alcohol dependence	0.00015	0.000747	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—AVP—alcohol dependence	0.00015	0.000746	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CHRM2—alcohol dependence	0.000147	0.000732	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—WASF1—alcohol dependence	0.000147	0.000731	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CHRM2—alcohol dependence	0.000144	0.000716	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—AVP—alcohol dependence	0.000139	0.000693	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—AVP—alcohol dependence	0.000136	0.000678	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—OPRM1—alcohol dependence	0.000135	0.000672	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—OPRM1—alcohol dependence	0.000132	0.000658	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ADH6—alcohol dependence	0.000132	0.000657	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—HTR2A—alcohol dependence	0.000128	0.000635	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—HTR2A—alcohol dependence	0.000125	0.000621	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—NPY—alcohol dependence	0.000125	0.000619	CbGpPWpGaD
Salbutamol—CYP3A4—Biological oxidations—POMC—alcohol dependence	0.000123	0.000609	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—NPY—alcohol dependence	0.000122	0.000605	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CRH—alcohol dependence	0.00012	0.000597	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HTR1B—alcohol dependence	0.00012	0.000597	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CRH—alcohol dependence	0.000118	0.000584	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HTR1B—alcohol dependence	0.000118	0.000584	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—HTR2A—alcohol dependence	0.000116	0.000576	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—HTR2A—alcohol dependence	0.000113	0.000564	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ADH1A—alcohol dependence	0.00011	0.000545	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—DRD4—alcohol dependence	0.000105	0.000522	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—DRD4—alcohol dependence	0.000103	0.00051	CbGpPWpGaD
Salbutamol—ADRB1—GPCR downstream signaling—POMC—alcohol dependence	0.000102	0.000507	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—CNR1—alcohol dependence	0.0001	0.000498	CbGpPWpGaD
Salbutamol—ADRB2—GPCR downstream signaling—POMC—alcohol dependence	9.98e-05	0.000496	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—CNR1—alcohol dependence	9.81e-05	0.000487	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—DRD2—alcohol dependence	9.78e-05	0.000486	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HTR7—alcohol dependence	9.78e-05	0.000486	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HTR7—alcohol dependence	9.57e-05	0.000476	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—DRD2—alcohol dependence	9.57e-05	0.000476	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ADH4—alcohol dependence	9.32e-05	0.000463	CbGpPWpGaD
Salbutamol—ADRB1—Signaling by GPCR—POMC—alcohol dependence	9.26e-05	0.00046	CbGpPWpGaD
Salbutamol—ADRB2—Signaling by GPCR—POMC—alcohol dependence	9.06e-05	0.00045	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—AVP—alcohol dependence	8.23e-05	0.000409	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—AVP—alcohol dependence	8.05e-05	0.0004	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ADH7—alcohol dependence	7.92e-05	0.000394	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GGT2—alcohol dependence	7.6e-05	0.000377	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ADH1B—alcohol dependence	6.95e-05	0.000345	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—HTR2A—alcohol dependence	6.85e-05	0.00034	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—HTR2A—alcohol dependence	6.7e-05	0.000333	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—MAOB—alcohol dependence	5.76e-05	0.000286	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—POMC—alcohol dependence	5.47e-05	0.000272	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—POMC—alcohol dependence	5.35e-05	0.000266	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—ALDH2—alcohol dependence	4.89e-05	0.000243	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GOT2—alcohol dependence	4.16e-05	0.000207	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—CYP2E1—alcohol dependence	3.91e-05	0.000194	CbGpPWpGaD
Salbutamol—ADRB1—Signaling Pathways—EP300—alcohol dependence	3.63e-05	0.00018	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GGT1—alcohol dependence	3.59e-05	0.000179	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—GOT1—alcohol dependence	3.59e-05	0.000179	CbGpPWpGaD
Salbutamol—ADRB2—Signaling Pathways—EP300—alcohol dependence	3.55e-05	0.000176	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—MAOA—alcohol dependence	3.22e-05	0.00016	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—POMC—alcohol dependence	2.1e-05	0.000104	CbGpPWpGaD
Salbutamol—CYP3A4—Metabolism—EP300—alcohol dependence	1.39e-05	6.91e-05	CbGpPWpGaD
